Skip to main content
. Author manuscript; available in PMC: 2021 Jul 5.
Published in final edited form as: J Neurooncol. 2020 Jul 5;148(3):501–508. doi: 10.1007/s11060-020-03541-5

Table 2.

Clinical outcomes of GTR versus lobectomy (unweighted)

Group Median
length of
follow-up
(months),
(IQR)		 Postoperative
KPS (IQR)		 Progression
Free
Survival
(months),
(95% CI)		 Local
Control
(months),
(95% CI)		 Overall
Survival
(months),
(95% CI)		 Death, n
(%)		 Complications,
n (%)
GTR 6 (2.9, 13.8) 80 (70, 90) 8.1 (6.3, 9.9) 11 (5.8, 16.1) 14.1 (6.9, 21.3) 23 (62.2) 2 (5.4)
Lobectomy 12.4 (5.1, 18.15) 80 (60, 90) 17.2 (6.1, 28.2) 14.4 (2.5, 26.3) 30.7 (10.7, 50.7) 10 (31.2) 3 (9.4)